Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease

Journal of Pediatrics

Volumn 161, Issue 4, 2012, Pages

  Karve, Sudeep ^a   Candrilli, Sean ^a   Kappelman, Michael D ^b   Tolleson Rinehart, Sue ^b   Tennis, Patricia ^a   Andrews, Elizabeth ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOMODULATING AGENT; SALICYLIC ACID; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADOLESCENT; ADULT; ADULT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DRUG COST; DRUG UTILIZATION; EMERGENCY CARE; ENTERITIS; FEASIBILITY STUDY; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PHARMACEUTICAL CARE; PRESCHOOL CHILD; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84866729692     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.03.045     Document Type: Article

References (30)

1. National Institutes of Health. The Autoimmune Diseases Coordinating Committee. US Progress in Autoimmune Diseases Research: Report to Congress, 2005 March. Available at: www.niaid.nih.gov/topics/autoimmune/documents/adccfinal. pdf accessed December 21, 2010.
2. A.N. Dey, and B. Bloom Summary Health Statistics for US Children: National Health Interview Survey, 2003 Vital Health Stat 10 223 2005 1 78
3. J.W. Varni, C.A. Limbers, and T.M. Burwinkle Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the Pedsql 4.0 Generic Core Scales Health Qual Life Outcomes 5 2007 43
4. J. Todd, C. Armon, A. Griggs, S. Poole, and S. Berman Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance compared with children with private insurance in Colorado and the United States Pediatrics 118 2006 577 585 (Pubitemid 46085413)
5. J. Bickston, H.C. Waters, O. Dabbous, B.I. Tang, and M. Rahman Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients J Manag Care Pharm 14 2008 352 362 (Pubitemid 351890850)
6. M.D. Kappelman, S.L. Rifas-Shiman, and C.Q. Porter Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults Gastroenterology 135 2008 1907 1913
7. D.A. Stempel, D.T. Kruzikas, R. Manjunath, R.S. Sandler, J.A. Galanko, and J.A. Finkelstein Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast J Pediatr 150 2007 162 167 (Pubitemid 46127557)
8. M. Abeles, J.D. Urman, A. Weinstein, M. Lowenstein, and N.F. Rothfield Systemic lupus erythematosus in the younger patient: survival studies J Rheumatol 7 1980 515 522 (Pubitemid 11160517)
9. M. Klein-Gitelman, A. Reiff, and E.D. Silverman Systemic lupus erythematosus in childhood Rheum Dis Clin North Am 28 2002 561 577 vi-vii
10. E. Langholz, P. Munkholm, P.A. Krasilnikoff, and V. Binder Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort Scand J Gastroenterol 32 1997 139 147 (Pubitemid 27075119)
11. E. Lindberg, B. Lindquist, L. Holmquist, and H. Hildebrand Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995 J Pediatr Gastroenterol Nutr 30 2000 259 264 (Pubitemid 30366831)
12. M.J. Molina, A.M. Mayor, A.E. Franco, C.A. Morell, M.A. López, and L.M. Vilá Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico J Clin Rheumatol 13 2007 202 204 (Pubitemid 47356788)
13. C. Pineau, C. Lee, R. Ramsey-Goldman, A. Clarke, and S. Bernatsky The second hit: comorbidities in systemic lupus erythematosus Future Rheumatology 2 2007 497 506 (Pubitemid 350001682)
14. C.N. Bernstein, A. Wajda, and J.F. Blanchard The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study Gastroenterology 129 2005 827 836 (Pubitemid 41242675)
15. X. Weng, L. Liu, L.F. Barcellos, J.E. Allison, and L.J. Herrinton Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization Am J Gastroenterol 102 2007 1429 1435 (Pubitemid 46976291)
16. C.S. Yee, N. Crabtree, J. Skan, N. Amft, S. Bowman, and D. Situnayake Prevalence and predictors of fragility fractures in systemic lupus erythematosus Ann Rheum Dis 64 2005 111 113 (Pubitemid 40075285)
17. T.P. Van Staa, C. Cooper, L.S. Brusse, H. Leufkens, M.K. Javaid, and N.K. Arden Inflammatory bowel disease and the risk of fracture Gastroenterology 125 2003 1591 1597 (Pubitemid 37500422)
18. I.E. Bultink, W.F. Lems, P.J. Kostense, B.A. Dijkmans, and A.E. Voskuyl Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus Arthritis Rheum 52 2005 2044 2050 (Pubitemid 40994328)
19. E.V. Loftus Jr., C.S. Crowson, W.J. Sandborn, W.J. Tremaine, W.M. O'fallon, and L.J. Melton III Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota Gastroenterology 123 2002 468 475 (Pubitemid 34827191)
20. P. Vestergaard, and L. Mosekilde Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16 416 patients in Denmark Am J Epidemiol 156 2002 1 10 (Pubitemid 34680618)
21. O. Abramson, M. Durant, and W. Mow Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in northern California, 1996-2006 J Pediatr 157 2010 233 239 E1
22. S. Bernatsky, L. Joseph, C.A. Pineau, R. Tamblyn, D.E. Feldman, and A.E. Clarke A population-based assessment of systemic lupus erythematosus incidence and prevalence - results and implications of using administrative data for epidemiological studies Rheumatology (Oxford) 46 2007 1814 1818 (Pubitemid 350168297)
23. G. Carls, T. Li, P. Panopalis, S. Wang, A.G. Mell, and T.B. Gibson Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis J Occup Environ Med 51 2009 66 79
24. M.B. Nichol, S. Shi, T.K. Knight, D.J. Wallace, and M.H. Weisman Eligibility, utilization, and costs in a California Medicaid lupus population Arthritis Rheum 51 2004 996 1003 (Pubitemid 39648194)
25. P. Panopalis, J. Yazdany, and J.Z. Gillis Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus Arthritis Rheum 59 2008 1788 1795
26. E.M. Pelletier, S. Ogale, E. Yu, P. Brunetta, and J. Garg Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database Clin Ther 31 2009 2653 2664
27. N. Sutcliffe, A.E. Clarke, R. Taylor, C. Frost, and D.A. Isenberg Total costs and predictors of costs in patients with systemic lupus erythematosus Rheumatology (Oxford) 40 2001 37 47
28. R.L. Fleurence, H. Naci, and J.P. Jansen The critical role of observational evidence in comparative effectiveness research Health Aff (Millwood) 29 2010 1826 1833
29. N.F. Marko, and R.J. Weil The role of observational investigations in comparative effectiveness research Value Health 13 2010 989 997
30. US Department of Health and Human Services: Food and Drug Administration. The Sentinel Initiative: A national strategy for monitoring medical product safety. 2008 May. Available at: http://www.fda.gov/safety/ fdassentinelinitiative/ucm089474.htm accessed January 24, 2011.